Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. Cash Flow Conversion Efficiency

Latest as of September 2025: 0.024x

Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. cash flow conversion efficiency. Based on the latest financial reports, Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. (605016) has a cash flow conversion efficiency ratio of 0.024x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥45.11 Million ≈ $6.60 Million USD) by net assets (CN¥1.88 Billion ≈ $274.76 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. (2016–2025)

Cash flow conversion efficiency of Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. from 2016 to 2025. This chart illustrates how Shandong Bailong Chuangyuan Bio-Tech Co. Ltd.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. View Shandong Bailong Chuangyuan Bio-Tech Co. stock quote for real-time trading data and today's change.

Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. Cash Flow Conversion Ratio Explained

Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. ranked by their cash flow conversion efficiency. Also see Shandong Bailong Chuangyuan Bio-Tech Co. market cap and net worth for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
UroGen Pharma Ltd NASDAQ:URGN	0.249x
Zotye Automobile Co Ltd SHE:000980	0.921x
United Corporations Limited TO:UNC	0.004x
Shenzhen Zhenye Group Co Ltd SHE:000006	-0.037x
Forestar Group Inc NYSE:FOR	0.083x
PagSeguro Digital Ltd NYSE:PAGS	0.032x
Universal Insurance Holdings Inc NYSE:UVE	0.159x
Sonic Automotive Inc NYSE:SAH	0.036x

Annual Cash Flow Conversion Efficiency for Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. (2016–2025)

The table below shows the annual cash flow conversion efficiency of Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. from 2016 to 2025. Review Shandong Bailong Chuangyuan Bio-Tech Co. free cash flow ratio to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥1.96 Billion ≈ $287.02 Million	CN¥135.45 Million ≈ $19.82 Million	0.069x	-61.46%
2024-12-31	CN¥1.68 Billion ≈ $245.73 Million	CN¥300.89 Million ≈ $44.03 Million	0.179x	+38.81%
2023-12-31	CN¥1.51 Billion ≈ $220.64 Million	CN¥194.63 Million ≈ $28.48 Million	0.129x	+15.88%
2022-12-31	CN¥1.34 Billion ≈ $196.81 Million	CN¥149.82 Million ≈ $21.92 Million	0.111x	+39.36%
2021-12-31	CN¥1.20 Billion ≈ $176.10 Million	CN¥96.20 Million ≈ $14.08 Million	0.080x	-54.65%
2020-12-31	CN¥691.09 Million ≈ $101.13 Million	CN¥121.82 Million ≈ $17.83 Million	0.176x	+64.25%
2019-12-31	CN¥597.07 Million ≈ $87.37 Million	CN¥64.08 Million ≈ $9.38 Million	0.107x	-39.58%
2018-12-31	CN¥501.71 Million ≈ $73.42 Million	CN¥89.12 Million ≈ $13.04 Million	0.178x	-31.68%
2017-12-31	CN¥436.41 Million ≈ $63.86 Million	CN¥113.47 Million ≈ $16.60 Million	0.260x	+56.90%
2016-12-31	CN¥362.67 Million ≈ $53.07 Million	CN¥60.10 Million ≈ $8.79 Million	0.166x	--

About Shandong Bailong Chuangyuan Bio-Tech Co. Ltd.

SHG:605016 China Packaged Foods

Market Cap

$1.21 Billion

CN¥8.27 Billion CNY

Market Cap Rank

#7833 Global

#1724 in China

Share Price

CN¥19.68

Change (1 day)

+1.65%

52-Week Range

CN¥17.25 - CN¥28.42

All Time High

CN¥29.93